The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Interventional X-ray Contrast and Imaging Agents Market Research Report 2024
Synopsis
A contrast agent (or contrast medium) is a substance used to increase the contrast of structures or fluids within the body in medical imaging.
The global Interventional X-ray Contrast and Imaging Agents market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Interventional X-ray Contrast and Imaging Agents is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Interventional X-ray Contrast and Imaging Agents is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Interventional X-ray Contrast and Imaging Agents include Bracco, General Electric, Guerbet, Fujifilm Visualsonics, Imax, J.B. Chemicals & Pharmaceuticals, Jodas Expoim, Lantheus Medical Imaging and Nano Therapeutics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Interventional X-ray Contrast and Imaging Agents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Interventional X-ray Contrast and Imaging Agents.
Report Scope
The Interventional X-ray Contrast and Imaging Agents market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Interventional X-ray Contrast and Imaging Agents market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Interventional X-ray Contrast and Imaging Agents manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bracco
General Electric
Guerbet
Fujifilm Visualsonics
Imax
J.B. Chemicals & Pharmaceuticals
Jodas Expoim
Lantheus Medical Imaging
Nano Therapeutics
Novalek Pharmaceuticals
Taejoon Pharm
Unijules Life Sciences
Segment by Type
Iodinated Contrast Media
Barium-Based Contrast Media
Microbubble Contrast Media
Other
Segment by Application
Heart Disease
Neurological
Urology
General Surgery
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Interventional X-ray Contrast and Imaging Agents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Interventional X-ray Contrast and Imaging Agents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
A contrast agent (or contrast medium) is a substance used to increase the contrast of structures or fluids within the body in medical imaging.
The global Interventional X-ray Contrast and Imaging Agents market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Interventional X-ray Contrast and Imaging Agents is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Interventional X-ray Contrast and Imaging Agents is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Interventional X-ray Contrast and Imaging Agents include Bracco, General Electric, Guerbet, Fujifilm Visualsonics, Imax, J.B. Chemicals & Pharmaceuticals, Jodas Expoim, Lantheus Medical Imaging and Nano Therapeutics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Interventional X-ray Contrast and Imaging Agents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Interventional X-ray Contrast and Imaging Agents.
Report Scope
The Interventional X-ray Contrast and Imaging Agents market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Interventional X-ray Contrast and Imaging Agents market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Interventional X-ray Contrast and Imaging Agents manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bracco
General Electric
Guerbet
Fujifilm Visualsonics
Imax
J.B. Chemicals & Pharmaceuticals
Jodas Expoim
Lantheus Medical Imaging
Nano Therapeutics
Novalek Pharmaceuticals
Taejoon Pharm
Unijules Life Sciences
Segment by Type
Iodinated Contrast Media
Barium-Based Contrast Media
Microbubble Contrast Media
Other
Segment by Application
Heart Disease
Neurological
Urology
General Surgery
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Interventional X-ray Contrast and Imaging Agents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Interventional X-ray Contrast and Imaging Agents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Interventional X-ray Contrast and Imaging Agents Market Overview
1.1 Product Overview and Scope of Interventional X-ray Contrast and Imaging Agents
1.2 Interventional X-ray Contrast and Imaging Agents Segment by Type
1.2.1 Global Interventional X-ray Contrast and Imaging Agents Market Value Comparison by Type (2024-2030)
1.2.2 Iodinated Contrast Media
1.2.3 Barium-Based Contrast Media
1.2.4 Microbubble Contrast Media
1.2.5 Other
1.3 Interventional X-ray Contrast and Imaging Agents Segment by Application
1.3.1 Global Interventional X-ray Contrast and Imaging Agents Market Value by Application: (2024-2030)
1.3.2 Heart Disease
1.3.3 Neurological
1.3.4 Urology
1.3.5 General Surgery
1.3.6 Other
1.4 Global Interventional X-ray Contrast and Imaging Agents Market Size Estimates and Forecasts
1.4.1 Global Interventional X-ray Contrast and Imaging Agents Revenue 2019-2030
1.4.2 Global Interventional X-ray Contrast and Imaging Agents Sales 2019-2030
1.4.3 Global Interventional X-ray Contrast and Imaging Agents Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Interventional X-ray Contrast and Imaging Agents Market Competition by Manufacturers
2.1 Global Interventional X-ray Contrast and Imaging Agents Sales Market Share by Manufacturers (2019-2024)
2.2 Global Interventional X-ray Contrast and Imaging Agents Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Interventional X-ray Contrast and Imaging Agents Average Price by Manufacturers (2019-2024)
2.4 Global Interventional X-ray Contrast and Imaging Agents Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Interventional X-ray Contrast and Imaging Agents, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Interventional X-ray Contrast and Imaging Agents, Product Type & Application
2.7 Interventional X-ray Contrast and Imaging Agents Market Competitive Situation and Trends
2.7.1 Interventional X-ray Contrast and Imaging Agents Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Interventional X-ray Contrast and Imaging Agents Players Market Share by Revenue
2.7.3 Global Interventional X-ray Contrast and Imaging Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Interventional X-ray Contrast and Imaging Agents Retrospective Market Scenario by Region
3.1 Global Interventional X-ray Contrast and Imaging Agents Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Interventional X-ray Contrast and Imaging Agents Global Interventional X-ray Contrast and Imaging Agents Sales by Region: 2019-2030
3.2.1 Global Interventional X-ray Contrast and Imaging Agents Sales by Region: 2019-2024
3.2.2 Global Interventional X-ray Contrast and Imaging Agents Sales by Region: 2025-2030
3.3 Global Interventional X-ray Contrast and Imaging Agents Global Interventional X-ray Contrast and Imaging Agents Revenue by Region: 2019-2030
3.3.1 Global Interventional X-ray Contrast and Imaging Agents Revenue by Region: 2019-2024
3.3.2 Global Interventional X-ray Contrast and Imaging Agents Revenue by Region: 2025-2030
3.4 North America Interventional X-ray Contrast and Imaging Agents Market Facts & Figures by Country
3.4.1 North America Interventional X-ray Contrast and Imaging Agents Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Interventional X-ray Contrast and Imaging Agents Sales by Country (2019-2030)
3.4.3 North America Interventional X-ray Contrast and Imaging Agents Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Interventional X-ray Contrast and Imaging Agents Market Facts & Figures by Country
3.5.1 Europe Interventional X-ray Contrast and Imaging Agents Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Interventional X-ray Contrast and Imaging Agents Sales by Country (2019-2030)
3.5.3 Europe Interventional X-ray Contrast and Imaging Agents Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Interventional X-ray Contrast and Imaging Agents Market Facts & Figures by Country
3.6.1 Asia Pacific Interventional X-ray Contrast and Imaging Agents Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Interventional X-ray Contrast and Imaging Agents Sales by Country (2019-2030)
3.6.3 Asia Pacific Interventional X-ray Contrast and Imaging Agents Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Interventional X-ray Contrast and Imaging Agents Market Facts & Figures by Country
3.7.1 Latin America Interventional X-ray Contrast and Imaging Agents Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Interventional X-ray Contrast and Imaging Agents Sales by Country (2019-2030)
3.7.3 Latin America Interventional X-ray Contrast and Imaging Agents Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Interventional X-ray Contrast and Imaging Agents Market Facts & Figures by Country
3.8.1 Middle East and Africa Interventional X-ray Contrast and Imaging Agents Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Interventional X-ray Contrast and Imaging Agents Sales by Country (2019-2030)
3.8.3 Middle East and Africa Interventional X-ray Contrast and Imaging Agents Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Interventional X-ray Contrast and Imaging Agents Sales by Type (2019-2030)
4.1.1 Global Interventional X-ray Contrast and Imaging Agents Sales by Type (2019-2024)
4.1.2 Global Interventional X-ray Contrast and Imaging Agents Sales by Type (2025-2030)
4.1.3 Global Interventional X-ray Contrast and Imaging Agents Sales Market Share by Type (2019-2030)
4.2 Global Interventional X-ray Contrast and Imaging Agents Revenue by Type (2019-2030)
4.2.1 Global Interventional X-ray Contrast and Imaging Agents Revenue by Type (2019-2024)
4.2.2 Global Interventional X-ray Contrast and Imaging Agents Revenue by Type (2025-2030)
4.2.3 Global Interventional X-ray Contrast and Imaging Agents Revenue Market Share by Type (2019-2030)
4.3 Global Interventional X-ray Contrast and Imaging Agents Price by Type (2019-2030)
5 Segment by Application
5.1 Global Interventional X-ray Contrast and Imaging Agents Sales by Application (2019-2030)
5.1.1 Global Interventional X-ray Contrast and Imaging Agents Sales by Application (2019-2024)
5.1.2 Global Interventional X-ray Contrast and Imaging Agents Sales by Application (2025-2030)
5.1.3 Global Interventional X-ray Contrast and Imaging Agents Sales Market Share by Application (2019-2030)
5.2 Global Interventional X-ray Contrast and Imaging Agents Revenue by Application (2019-2030)
5.2.1 Global Interventional X-ray Contrast and Imaging Agents Revenue by Application (2019-2024)
5.2.2 Global Interventional X-ray Contrast and Imaging Agents Revenue by Application (2025-2030)
5.2.3 Global Interventional X-ray Contrast and Imaging Agents Revenue Market Share by Application (2019-2030)
5.3 Global Interventional X-ray Contrast and Imaging Agents Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Bracco
6.1.1 Bracco Corporation Information
6.1.2 Bracco Description and Business Overview
6.1.3 Bracco Interventional X-ray Contrast and Imaging Agents Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bracco Interventional X-ray Contrast and Imaging Agents Product Portfolio
6.1.5 Bracco Recent Developments/Updates
6.2 General Electric
6.2.1 General Electric Corporation Information
6.2.2 General Electric Description and Business Overview
6.2.3 General Electric Interventional X-ray Contrast and Imaging Agents Sales, Revenue and Gross Margin (2019-2024)
6.2.4 General Electric Interventional X-ray Contrast and Imaging Agents Product Portfolio
6.2.5 General Electric Recent Developments/Updates
6.3 Guerbet
6.3.1 Guerbet Corporation Information
6.3.2 Guerbet Description and Business Overview
6.3.3 Guerbet Interventional X-ray Contrast and Imaging Agents Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Guerbet Interventional X-ray Contrast and Imaging Agents Product Portfolio
6.3.5 Guerbet Recent Developments/Updates
6.4 Fujifilm Visualsonics
6.4.1 Fujifilm Visualsonics Corporation Information
6.4.2 Fujifilm Visualsonics Description and Business Overview
6.4.3 Fujifilm Visualsonics Interventional X-ray Contrast and Imaging Agents Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Fujifilm Visualsonics Interventional X-ray Contrast and Imaging Agents Product Portfolio
6.4.5 Fujifilm Visualsonics Recent Developments/Updates
6.5 Imax
6.5.1 Imax Corporation Information
6.5.2 Imax Description and Business Overview
6.5.3 Imax Interventional X-ray Contrast and Imaging Agents Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Imax Interventional X-ray Contrast and Imaging Agents Product Portfolio
6.5.5 Imax Recent Developments/Updates
6.6 J.B. Chemicals & Pharmaceuticals
6.6.1 J.B. Chemicals & Pharmaceuticals Corporation Information
6.6.2 J.B. Chemicals & Pharmaceuticals Description and Business Overview
6.6.3 J.B. Chemicals & Pharmaceuticals Interventional X-ray Contrast and Imaging Agents Sales, Revenue and Gross Margin (2019-2024)
6.6.4 J.B. Chemicals & Pharmaceuticals Interventional X-ray Contrast and Imaging Agents Product Portfolio
6.6.5 J.B. Chemicals & Pharmaceuticals Recent Developments/Updates
6.7 Jodas Expoim
6.6.1 Jodas Expoim Corporation Information
6.6.2 Jodas Expoim Description and Business Overview
6.6.3 Jodas Expoim Interventional X-ray Contrast and Imaging Agents Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Jodas Expoim Interventional X-ray Contrast and Imaging Agents Product Portfolio
6.7.5 Jodas Expoim Recent Developments/Updates
6.8 Lantheus Medical Imaging
6.8.1 Lantheus Medical Imaging Corporation Information
6.8.2 Lantheus Medical Imaging Description and Business Overview
6.8.3 Lantheus Medical Imaging Interventional X-ray Contrast and Imaging Agents Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Lantheus Medical Imaging Interventional X-ray Contrast and Imaging Agents Product Portfolio
6.8.5 Lantheus Medical Imaging Recent Developments/Updates
6.9 Nano Therapeutics
6.9.1 Nano Therapeutics Corporation Information
6.9.2 Nano Therapeutics Description and Business Overview
6.9.3 Nano Therapeutics Interventional X-ray Contrast and Imaging Agents Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Nano Therapeutics Interventional X-ray Contrast and Imaging Agents Product Portfolio
6.9.5 Nano Therapeutics Recent Developments/Updates
6.10 Novalek Pharmaceuticals
6.10.1 Novalek Pharmaceuticals Corporation Information
6.10.2 Novalek Pharmaceuticals Description and Business Overview
6.10.3 Novalek Pharmaceuticals Interventional X-ray Contrast and Imaging Agents Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Novalek Pharmaceuticals Interventional X-ray Contrast and Imaging Agents Product Portfolio
6.10.5 Novalek Pharmaceuticals Recent Developments/Updates
6.11 Taejoon Pharm
6.11.1 Taejoon Pharm Corporation Information
6.11.2 Taejoon Pharm Interventional X-ray Contrast and Imaging Agents Description and Business Overview
6.11.3 Taejoon Pharm Interventional X-ray Contrast and Imaging Agents Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Taejoon Pharm Interventional X-ray Contrast and Imaging Agents Product Portfolio
6.11.5 Taejoon Pharm Recent Developments/Updates
6.12 Unijules Life Sciences
6.12.1 Unijules Life Sciences Corporation Information
6.12.2 Unijules Life Sciences Interventional X-ray Contrast and Imaging Agents Description and Business Overview
6.12.3 Unijules Life Sciences Interventional X-ray Contrast and Imaging Agents Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Unijules Life Sciences Interventional X-ray Contrast and Imaging Agents Product Portfolio
6.12.5 Unijules Life Sciences Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Interventional X-ray Contrast and Imaging Agents Industry Chain Analysis
7.2 Interventional X-ray Contrast and Imaging Agents Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Interventional X-ray Contrast and Imaging Agents Production Mode & Process
7.4 Interventional X-ray Contrast and Imaging Agents Sales and Marketing
7.4.1 Interventional X-ray Contrast and Imaging Agents Sales Channels
7.4.2 Interventional X-ray Contrast and Imaging Agents Distributors
7.5 Interventional X-ray Contrast and Imaging Agents Customers
8 Interventional X-ray Contrast and Imaging Agents Market Dynamics
8.1 Interventional X-ray Contrast and Imaging Agents Industry Trends
8.2 Interventional X-ray Contrast and Imaging Agents Market Drivers
8.3 Interventional X-ray Contrast and Imaging Agents Market Challenges
8.4 Interventional X-ray Contrast and Imaging Agents Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
